In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped reduce levels of brain atrophy and neuroinflammation.

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.

Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...

The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

Dartmouth Health is the only health care system on the East Coast to be part of the newly launched Brain Health Navigator ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

Sleep disturbances are common in old age, but drastic changes, such as waking up at 3 am or not being able to stay awake ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

A new USC-led study suggests that assessing blood vessel health should be included in dementia diagnostics. A new USC-led ...

Leqembi's subcutaneous dosing allows Alzheimer's patients to administer weekly treatment at home in 15 seconds ... s disease ...